Brussels, 4–6 November; hybrid format with online networking day

Innovative Health Initiative Brokerage Event: registration open for consortia-building ahead of the next calls

networking

Registration is open for the Brokerage Event in Brussels on 4–5 November, with an additional online networking day on 6 November. The event is designed to help applicants meet partners, shape proposals and understand what makes a robust consortium for the next applicant‑driven call expected in early 2026. Details and sign‑up are available via the official platform: ihicalldays2025.converve.io. The event outline confirms pitching sessions, poster displays, one‑to‑one meetings and short guidance briefings, with key sessions streamed online for remote participants IHI Brokerage Event 2025.

The Innovative Health Initiative (IHI) funds large, cross‑sector research and innovation projects that address unmet public health needs. The next applicant‑driven call (IHI call 12) is indicatively foreseen for early 2026 and will continue the approach piloted in call 9, asking applicants to identify opportunities within IHI’s Strategic Research and Innovation Agenda. It will be a standard single‑stage call, with at least half of project costs covered by in‑kind contributions from industry/contributing partners.

The brokerage format is straightforward: people with project ideas can pitch to find complementary expertise; organisations can present posters to signal interest; and small rooms are available for longer discussions among emerging consortia. An opening briefing and “ask the experts” session on day one provide practical tips on consortium composition, eligibility and submission. The online platform remains open for partner search and networking until the call deadline IHI Brokerage Event 2025.

Large European health partnerships already funded under Horizon Europe illustrate the scale and structure of the consortia that typically apply to IHI. ERDERA, for example, is a multi‑country consortium bringing together public and private organisations across disciplines to accelerate research translation in rare diseases—an approach that mirrors the cross‑sector collaboration and patient‑centred focus expected in IHI projects.

Teams preparing to apply may wish to register early, map required expertise (including industry partners and patient involvement), and use the platform to identify gaps. Registration link: ihicalldays2025.converve.io. Future call information: IHI future opportunities.

News & Updates

You might also be interested in

November 2 @ 1:00 pm - 2:00 pm
ERDERA Ethics & Regulatory Webinar Series
November 25 - November 26
Discover practical pathways to repurpose medicines for rare diseases, exchange experiences and best practices between underrepresented and high-performing countries, and build new partnerships at the ERDERA Knowledge Exchange Meeting in Riga on 25-26 November.
ERDERA contributed to the first Journée nationale FrBioNet, bringing a European rare disease perspective to discussions with the French biobanking community.
ERDERA will return to the World Orphan Drug Congress Europe with a booth and an interactive pre-conference workshop examining where artificial intelligence can support rare disease research and therapeutic development, and where human expertise remains essential.